A detailed history of Greenwood Gearhart Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Greenwood Gearhart Inc holds 1,090 shares of ABBV stock, worth $191,382. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,090
Holding current value
$191,382
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $178,585 - $217,269
1,090 New
1,090 $215,000
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $172,825 - $194,642
1,256 New
1,256 $194,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Greenwood Gearhart Inc Portfolio

Follow Greenwood Gearhart Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Gearhart Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Gearhart Inc with notifications on news.